IXEKIZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 17:45:58 GMT 2025` Edited by `admin` on `Tue Apr 01 17:45:58 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG4
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	BTY153760O
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

IXEKIZUMAB

Official Name

English

TALTZ

Preferred Name

English

LY-2439821

Code

English

IXEKIZUMAB [USAN]

Common Name

English

IXEKIZUMAB [JAN]

Common Name

English

IXEKIZUMAB [PURPLE BOOK CDER]

Common Name

English

Ixekizumab [WHO-DD]

Common Name

English

ixekizumab [INN]

Common Name

English

LY2439821

Code

English

IXEKIZUMAB [MI]

Common Name

English

Classification Tree Code System Code

EMA ASSESSMENT REPORTS

TALTZ (AUTHORIZED: PSORIASIS)

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

WHO-ATC

L04AC13

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

NDF-RT

N0000191495

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

Code System Code Type Description

DAILYMED

BTY153760O

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

PRIMARY

ChEMBL

CHEMBL1743034

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

PRIMARY

CAS

1143503-69-8

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

PRIMARY

MERCK INDEX

m11937

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

PRIMARY

WIKIPEDIA

IXEKIZUMAB

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

PRIMARY

FDA UNII

BTY153760O

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

PRIMARY

NCI_THESAURUS

C174646

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

PRIMARY

LACTMED

Ixekizumab

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

PRIMARY

DRUG CENTRAL

5083

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

PRIMARY

USAN

XX-56

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

PRIMARY

SMS_ID

100000162570

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

PRIMARY

NDF-RT

N0000191494

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

PRIMARY

Interleukin-17A Antagonists [MoA]

DRUG BANK

DB11569

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

PRIMARY

EVMPD

SUB176389

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

PRIMARY

RXCUI

1745099

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

PRIMARY

INN

9467

Created by admin on Tue Apr 01 17:45:58 GMT 2025 , Edited by admin on Tue Apr 01 17:45:58 GMT 2025

PRIMARY

From	To
1_22	1_96
1_146	1_202
1_260	1_320
1_366	1_424
2_22	2_96
2_146	2_202
2_260	2_320
2_366	2_424
3_23	3_93
3_139	3_199
4_23	4_93
4_139	4_199
1_133	3_219
2_133	4_219
1_225	2_225
1_228	2_228

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_296
N	2_296

Related Record Type Details


					R44E6C7B6J

INTERLEUKIN-17A

TARGET -> INHIBITOR

Related Record Type Details


					BTY153760O

ACTIVE MOIETY

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION			1_1; 2_1		PIDOLIC ACID	SZB83O1W42

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Volume of Distribution	PHARMACOKINETIC

Biological Half-life	PHARMACOKINETIC

Molecular Formula	CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL